Kimberly-Clark Work in process decreased by 2.0% to $146.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.4%, from $193.00M to $146.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows a downward trend with a -4.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $235.00M | $234.00M | $242.00M | $249.00M | $265.00M | $253.00M | $246.00M | $244.00M | $220.00M | $203.00M | $211.00M | $207.00M | $200.00M | $199.00M | $148.00M | $193.00M | $152.00M | $164.00M | $149.00M | $146.00M |
| QoQ Change | — | -0.4% | +3.4% | +2.9% | +6.4% | -4.5% | -2.8% | -0.8% | -9.8% | -7.7% | +3.9% | -1.9% | -3.4% | -0.5% | -25.6% | +30.4% | -21.2% | +7.9% | -9.1% | -2.0% |
| YoY Change | — | — | — | — | +12.8% | +8.1% | +1.7% | -2.0% | -17.0% | -19.8% | -14.2% | -15.2% | -9.1% | -2.0% | -29.9% | -6.8% | -24.0% | -17.6% | +0.7% | -24.4% |
| % of Inventories | 10.2% | 10.1% | 9.8% | 10.0% | 10.6% | 10.0% | 9.8% | 9.9% | 9.4% | 9.2% | 9.8% | 9.9% | 9.4% | 9.3% | 9.0% | 9.1% | 8.6% | 9.4% | 8.9% | 8.7% |
| Share Change | — | -0.1pp | -0.3pp | +0.1pp | +0.6pp | -0.6pp | -0.2pp | +0.1pp | -0.5pp | -0.3pp | +0.7pp | +0.1pp | -0.5pp | -0.1pp | -0.4pp | +0.2pp | -0.5pp | +0.8pp | -0.4pp | -0.2pp |